367 related articles for article (PubMed ID: 7832783)
1. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.
Bouton MC; Jandrot-Perrus M; Moog S; Cazenave JP; Guillin MC; Lanza F
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):635-41. PubMed ID: 7832783
[TBL] [Abstract][Full Text] [Related]
2. Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity.
Jandrot-Perrus M; Clemetson KJ; Huisse MG; Guillin MC
Blood; 1992 Dec; 80(11):2781-6. PubMed ID: 1450405
[TBL] [Abstract][Full Text] [Related]
3. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.
Li CQ; Vindigni A; Sadler JE; Wardell MR
J Biol Chem; 2001 Mar; 276(9):6161-8. PubMed ID: 11024046
[TBL] [Abstract][Full Text] [Related]
4. Thrombin interaction with platelet membrane glycoprotein Ib.
Jandrot-Perrus M; Bouton MC; Lanza F; Guillin MC
Semin Thromb Hemost; 1996; 22(2):151-6. PubMed ID: 8807712
[TBL] [Abstract][Full Text] [Related]
5. Late-fibrin(ogen) fragment E modulates human alpha-thrombin specificity.
Bouton MC; Jandrot-Perrus M; Bezeaud A; Guillin MC
Eur J Biochem; 1993 Jul; 215(1):143-9. PubMed ID: 8393788
[TBL] [Abstract][Full Text] [Related]
6. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
Ye J; Liu LW; Esmon CT; Johnson AE
J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
[TBL] [Abstract][Full Text] [Related]
7. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha.
De Marco L; Mazzucato M; Masotti A; Ruggeri ZM
J Biol Chem; 1994 Mar; 269(9):6478-84. PubMed ID: 8119999
[TBL] [Abstract][Full Text] [Related]
8. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
Myles T; Le Bonniec BF; Stone SR
Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104
[TBL] [Abstract][Full Text] [Related]
9. Structure-function relationships of the thrombin-thrombomodulin interaction.
Sadler JE; Lentz SR; Sheehan JP; Tsiang M; Wu Q
Haemostasis; 1993 Mar; 23 Suppl 1():183-93. PubMed ID: 8388351
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
11. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.
Fenton JW; Olson TA; Zabinski MP; Wilner GD
Biochemistry; 1988 Sep; 27(18):7106-12. PubMed ID: 3196704
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the thrombin binding sites on fibrin.
Meh DA; Siebenlist KR; Mosesson MW
J Biol Chem; 1996 Sep; 271(38):23121-5. PubMed ID: 8798504
[TBL] [Abstract][Full Text] [Related]
13. The fibrinogen anion-binding exosite of thrombin is necessary for induction of rises in intracellular calcium and prostacyclin production in endothelial cells.
Ngaiza JR; Manley G; Grulich-Henn J; Krstenansky JL; Jaffe EA
J Cell Physiol; 1992 Apr; 151(1):190-6. PubMed ID: 1560043
[TBL] [Abstract][Full Text] [Related]
14. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
Mosesson MW; Hernandez I; Siebenlist KR
Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
[TBL] [Abstract][Full Text] [Related]
15. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
16. The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptor.
Blackhart BD; Cuenco G; Toda T; Scarborough RM; Wolf DL; Ramakrishnan V
Growth Factors; 1994; 11(1):17-28. PubMed ID: 7833057
[TBL] [Abstract][Full Text] [Related]
17. Thrombin specificity.
Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
[TBL] [Abstract][Full Text] [Related]
19. Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation.
Liu L; Freedman J; Hornstein A; Fenton JW; Song Y; Ofosu FA
J Biol Chem; 1997 Jan; 272(3):1997-2004. PubMed ID: 8999892
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo.
Hassan S; Sainz IM; Khan MM; Bradford HN; Isordia-Salas I; Kashem SW; Sartor RB; Colman RW
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2959-65. PubMed ID: 17293494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
